John W. Ullrich
Rhône-Poulenc
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by John W. Ullrich.
Bioorganic & Medicinal Chemistry Letters | 2010
John W. Ullrich; Robert M. Morris; Ronald C. Bernotas; Jeremy M. Travins; James W. Jetter; Rayomand J. Unwalla; Elaine Quinet; Ponnal Nambi; Irene Feingold; Christine Huselton; Christofer Enroth; Anna Wilhelmsson; Annika Goos-Nilsson; Jay E. Wrobel
A series of 4-(3-biaryl)quinolines with sulfone substituents on the terminal aryl ring (8) was prepared as potential LXR agonists. High affinity LXRbeta ligands with generally modest binding selectivity over LXRalpha and excellent agonist potency in LXR functional assays were identified. Many compounds had LXRbeta binding IC(50) values <10 nM while the most potent had EC(50) values <1.0 nM in an ABCA1 mRNA induction assay in J774 mouse cells with efficacy comparable to T0901317. Sulfone 8a was further evaluated in LDL (-/-) mice and shown to reduce atherosclerotic lesion progression.
Angewandte Chemie | 1998
Christopher J. Burns; Robert Groneberg; Joseph M. Salvino; Gerard M. McGeehan; Stephen M. Condon; Robert Morris; Matthew M. Morrissette; Rose Mathew; Shelley Darnbrough; Kent W. Neuenschwander; Anthony C. Scotese; Stevan W. Djuric; John W. Ullrich; Richard Labaudiniere
Uber nureinen Syntheseweg lassen sich Bibliotheken aus niedermolekularen Verbindungen aufbauen, die auf zwei Targetfamilien mit unterschiedlichen Funktionalitaten ausgerichtet sind. Dies wurde anhand der Entdeckung des Strukturtemplats 1 deutlich, das voneinander unabhangige pharmakophore Muster enthalt, uber die Mitglieder aus einer von zwei Targetfamilien, den Matrix-Metalloproteinasen (MMPs) oder den Phosphodiesterasen (PDEs), inhibiert werden konnen. Durch den Einbau von Bausteinen, die gegen mehrere Targets gerichtet sind, in eine Verbindungsbibliothek kann man so moglicherweise das Auffinden pharmazeutischer Leitstrukuren beschleunigen. Z=OR′ (PDE4), H (MMPs).
Archive | 1988
John W. Ullrich; Kent W. Neuenschwander; John R. Regan
Archive | 2004
Michael D. Collini; Robert R. Singhaus; Baihua Hu; James W. Jetter; Robert L. Morris; David H. Kaufman; Chris P. Miller; John W. Ullrich; Rayomand J. Unwalla; Jay E. Wrobel; Elaine Quinet; Ponnal Nambi; Ronald C. Bernotas; Merle Elloso
Journal of Medicinal Chemistry | 1999
Robert Groneberg; Christopher J. Burns; Matthew M. Morrissette; John W. Ullrich; Robert L. Morris; Shelley Darnbrough; Stevan W. Djuric; Stephen M. Condon; Gerard M. McGeehan; Richard Labaudiniere; Kent W. Neuenschwander; and Anthony C. Scotese; Jane Kline
Archive | 2005
Robert J. Steffan; Edward Martin Matelan; Stephen M. Bowen; John W. Ullrich; Jay E. Wrobel; Edouard Zamaratski; Lars Krüger; Annabel L. Olsen Hedemyr; Aiping Cheng; Tomas Hansson; Rayomand J. Unwalla; Crhistopher P. Miller; Patrick Rhönnstad
Archive | 2000
John W. Ullrich; Andrew Fensome; Jay E. Wrobel; Lin Zhi; Todd K. Jones; James P. Edwards; Christopher M. Tegley
Archive | 2002
Chris P. Miller; Michael D. Collini; David H. Kaufman; Robert L. Morris; Robert Ray Singhaus; John W. Ullrich; Heather A. Harris; James C. Keith; Leo M. Albert; Rayomand J. Unwalla
Archive | 2000
Andrew Fensome; Lori L. Miller; John W. Ullrich; Reinhold H. W. Bender; Puwen Zhang; Jay E. Wrobel; Lin Zhi; Todd K. Jones; Keith B. Marschke; Christopher M. Tegley; James P. Edwards
Archive | 2001
Gary S. Grubb; John W. Ullrich; Andrew Fensome; Jay E. Wrobel; James P. Edwards; Todd K. Jones; Christopher M. Tegley; Lin Zhi